Truist Securities Maintains Buy on Ardent Health, Raises Price Target to $13
Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $12 to $13.
Read original at benzingaStocks · News reference
RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $13
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and raises the price target from $12 to $13.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 10, 2026, 4:03 PM
- Checked
- Aug 10, 2026, 4:03 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Guggenheim Maintains Buy on Ardent Health, Raises Price Target to $14
Guggenheim analyst Jason Cassorla maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $14.
Read original at benzingaArdent Health shares are trading higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance with its midpoint above estimates.
Read original at benzinga